Target intelligence / Profile preview

Urokinase plasminogen activator surface receptor (uPAR)

Target
uPAR
Molecular classification
Receptor, GPI-anchored protein, Ly6/uPAR family protein
01

Overview

Urokinase plasminogen activator surface receptor (uPAR, encoded by the PLAUR gene) is a glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein that plays a central role in regulating pericellular proteolysis, cell migration, and tissue remodeling. By binding its primary ligand, urokinase-type plasminogen activator (uPA), uPAR localizes and accelerates the conversion of plasminogen to plasmin, initiating a proteolytic cascade that degrades the extracellular matrix. Beyond its proteolytic functions, uPAR acts as a signaling hub by forming lateral complexes with transmembrane co-receptors, such as integrins, G-protein coupled receptors, and EGFR, thereby activating downstream FAK/Src, MAPK, and PI3K/Akt pathways to promote cell survival, proliferation, and epithelial-mesenchymal transition.

In pathological contexts, uPAR is highly overexpressed in various solid tumors (including breast, prostate, pancreatic, and ovarian cancers, as well as glioblastoma) and is strongly associated with tumor invasion, metastasis, angiogenesis, and poor patient prognosis. It is also a marker of cellular senescence and is implicated in chronic inflammatory, fibrotic, and cardiovascular diseases. Therapeutic strategies targeting uPAR include monoclonal antibodies (such as huATN-658) that disrupt uPAR-integrin signaling, uPAR-targeted CAR-T cells designed to eliminate both tumor cells and senescent/suppressive stromal cells, and radiolabeled peptides (such as 64Cu-DOTA-AE105) for PET imaging and targeted radionuclide therapy. However, drug development faces challenges such as potential on-target/off-tumor toxicities due to low-level uPAR expression in normal tissues (e.g., endothelial cells, leukocytes, and renal tubules) and the shedding of active soluble uPAR (suPAR).

Other names
PLAURCD87U-PARURKRMonocyte activation antigen Mo3
02

Mechanism of action

Inhibition of uPAR-integrin interaction, disruption of uPA-uPAR binding, targeted cellular cytotoxicity via CAR-T cells, and targeted radionuclide imaging or therapy

03

Biological functions

Cell migrationCell adhesionProteolysisSignal transductionExtracellular matrix degradationCellular senescence
04

Disease associations

CancerInflammationFibrosisInfectionCardiovascular disease
05

Safety considerations

On-target/off-tumor toxicity due to low physiological expression in normal tissues such as endothelial cells, activated leukocytes, renal tubular epithelium, and liver sinusoidal cellsAntigen escape or shedding of soluble uPAR (suPAR) under therapeutic pressureImmunosuppressive tumor microenvironment limiting CAR-T cell trafficking and persistence
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Soluble urokinase plasminogen activator receptor (suPAR)uPAR expression levelPLAUR methylation level

Beyond the preview

Go deeper on Urokinase plasminogen activator surface receptor (uPAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urokinase plasminogen activator surface receptor (uPAR).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call